TIA
GSK icon

Trust Investment Advisors’s GSK GSK Stock Holding History

Trust Investment Advisors’s Portfolio GSK Stock Details GSK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q4 		– Sell
-10,728
Closed -$539K – 83
2018
Q3 		$539K Sell
10,728
-200
-2% -$10.2K 0.55% 69
2018
Q2 		$551K Sell
10,928
-980
-8% -$49.4K 0.61% 67
2018
Q1 		$582K Sell
11,908
-2,640
-18% -$123K 0.67% 64
2017
Q4 		$645K Sell
14,548
-9,360
-39% -$432K 0.72% 57
2017
Q3 		$1.21M Sell
23,908
-3,160
-12% -$160K 1.37% 29
2017
Q2 		$1.46M Buy
27,068
+596
+2% +$31.8K 1.57% 16
2017
Q1 		$1.4M Buy
26,472
+5,280
+25% +$268K 1.5% 18
2016
Q4 		$1.02M Sell
21,192
-5,180
-20% -$256K 1.16% 44
2016
Q3 		$1.42M Buy
26,372
+560
+2% +$30.7K 1.62% 11
2016
Q2 		$1.4M Buy
25,812
+80
+0.3% +$4.21K 1.65% 15
2016
Q1 		$1.3M Buy
+25,732
New +$1.28M 1.47% 17

Other funds holding GSK

Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
Fisher Asset Management
Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $185B AUM 39.58% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
BCIM
Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Trust Investment Advisors's GSK Position: Q4 2018 in Review

Trust Investment Advisors sold out of GSK (GSK) in Q4 2018, closing a stake of 10,728 shares — an estimated $539K sold.

Trust Investment Advisors first reported a position in GSK in Q1 2016 and held it in 11 quarters. The position peaked at $1.46M in Q2 2017. 799 funds tracked by Wall St. Rank hold GSK as of Q4 2018.

  • Trust Investment Advisors reported no remaining GSK position as of Q4 2018 after selling out during the quarter.
  • Trust Investment Advisors sold 10,728 GSK shares in Q4 2018, an estimated $539K.
  • Trust Investment Advisors first reported a position in GSK in Q1 2016 and held it in 11 quarters.
  • Trust Investment Advisors's GSK position peaked at $1.46M in Q2 2017.
  • 799 funds tracked by Wall St. Rank held GSK as of Q4 2018.

Based on Trust Investment Advisors's 13F filing for Q4 2018, filed 6 Feb 2019.